BioLight Life Sciences Ltd. (TLV: BOLT)

BioLight Life Sciences Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.37	5.28	13.39	33.47	29.99	35.35
Short-Term Investments	-	0.25	1.25	0.25	1.16	4.6
Trading Asset Securities	12.06	3.12	2.99	-	19.96	-
Cash & Short-Term Investments	13.42	8.64	17.63	33.71	51.11	39.95
Cash Growth	3.15%	-50.96%	-47.72%	-34.04%	27.93%	-8.04%
Accounts Receivable	-	-	-	-	-	0
Other Receivables	0.66	-	-	0	0.09	0.56
Receivables	0.66	-	-	0	0.09	0.57
Prepaid Expenses	-	0.07	0.09	0.04	0.01	0.12
Other Current Assets	-	0.34	0.31	0.25	0.25	0.08
Total Current Assets	14.08	9.06	18.02	34	51.46	40.71
Property, Plant & Equipment	4.42	4.27	3.34	3.26	3.16	0.71
Long-Term Investments	16.35	19.37	34.88	25.82	10.06	28.61
Goodwill	-	-	-	-	0.15	3.87
Other Intangible Assets	0.69	0.69	0.69	0.15	-	0.04
Other Long-Term Assets	0.25	0.07	0.09	0.95	-	1
Total Assets	35.79	33.45	57.01	64.17	64.83	74.95
Accounts Payable	0.15	0.24	0.3	0.15	0.58	0.22
Accrued Expenses	2.53	1.51	1.71	1.62	1.52	2.74
Current Portion of Leases	0.53	0.09	0.53	0.44	0.46	0.45
Current Unearned Revenue	-	0.48	-	-	-	0.02
Other Current Liabilities	-	-	-	-	-	0.14
Total Current Liabilities	3.21	2.32	2.54	2.21	2.56	3.57
Long-Term Leases	0.31	-	-	-	0.47	-
Long-Term Unearned Revenue	0.88	0.84	0.78	0.54	0.56	2.23
Long-Term Deferred Tax Liabilities	-	-	-	-	1.13	1.01
Total Liabilities	4.4	3.15	3.32	2.75	4.72	6.8
Common Stock	11.65	11.65	11.44	11.4	11.36	11.36
Additional Paid-In Capital	250.89	250.78	250.46	250.42	248.34	248.17
Retained Earnings	-241.99	-242.82	-216.8	-208.96	-209.34	-195.96
Comprehensive Income & Other	10.67	10.17	8.07	7.84	8.86	5.29
Total Common Equity	31.23	29.78	53.17	60.7	59.22	68.86
Minority Interest	0.16	0.53	0.52	0.72	0.89	-0.72
Shareholders' Equity	31.38	30.3	53.69	61.42	60.11	68.15
Total Liabilities & Equity	35.79	33.45	57.01	64.17	64.83	74.95
Total Debt	0.85	0.09	0.53	0.44	0.93	0.45
Net Cash (Debt)	12.58	8.55	17.1	33.27	50.18	39.5
Net Cash Growth	-1.30%	-49.98%	-48.61%	-33.70%	27.04%	-9.08%
Net Cash Per Share	2.70	1.84	3.74	7.25	11.05	8.69
Filing Date Shares Outstanding	4.66	4.66	4.64	4.56	4.54	4.54
Total Common Shares Outstanding	4.66	4.66	4.58	4.56	4.54	4.54
Working Capital	10.87	6.74	15.49	31.79	48.9	37.14
Book Value Per Share	6.70	6.39	11.62	13.31	13.04	15.16
Tangible Book Value	30.54	29.09	52.48	60.55	59.07	64.95
Tangible Book Value Per Share	6.56	6.25	11.47	13.28	13.00	14.30
Machinery	-	0.64	0.64	0.54	0.54	0.81
Leasehold Improvements	-	0.07	0.07	0.07	0.19	0.13

Source: S&P Capital IQ. Standard template. Financial Sources.